SPAC607.02c Antibody

What is SPAC607.02c and why is it studied in research?

SPAC607.02c is a gene that encodes a conserved fungal protein in Schizosaccharomyces pombe (fission yeast), classified as a UPF0653 protein C607.02c with UniProt accession number Q9US15 . While its exact function remains under investigation, studying this protein contributes to our understanding of basic cellular processes in eukaryotes. S. pombe serves as an excellent model organism for investigating conserved eukaryotic processes like DNA repair, cell division, and stress responses, making SPAC607.02c antibodies valuable tools for such research.

What types of SPAC607.02c antibodies are available for research applications?

Commercially available SPAC607.02c antibodies are primarily rabbit polyclonal antibodies designed specifically for Schizosaccharomyces pombe research . These antibodies are typically generated using recombinant protein or synthetic peptide immunogens derived from the SPAC607.02c sequence. The antibodies are available in various formats, including standard research quantities (0.1-2ml) and larger amounts (10mg) for extensive studies . The polyclonal nature provides recognition of multiple epitopes, enhancing detection sensitivity while potentially introducing more variability compared to monoclonal alternatives.

What are the validated applications for SPAC607.02c antibody?

Based on available product information, SPAC607.02c antibodies have been validated for the following applications:

Most research antibodies undergo validation through ELISA testing and Western blot verification to confirm binding specificity . The antibody has been specifically optimized for detecting SPAC607.02c in S. pombe strain 972/ATCC 24843 samples, with potential cross-reactivity profiles requiring additional validation for other fission yeast strains .

How can I optimize Western blot protocols specifically for SPAC607.02c detection?

For optimal Western blot detection of SPAC607.02c, consider implementing the following methodology:

• Lysate preparation: Use glass bead disruption of cell walls in NP-40 buffer (6 mM Na₂HPO₄, 4 mM NaH₂PO₄, 1.0% NP-40, 150 mM NaCl, 2 mM EDTA, 50 mM NaF, 100 μM Na₃VO₄, 4 μg of leupeptin/ml) with protease inhibitors .

• Protein denaturation: For complete denaturation, heat samples to 95°C in SDS lysis buffer (10 mM NaPO₄ [pH 7.4], 1.0% SDS, 1 mM dithiothreitol, 1 mM EDTA, 50 mM NaF, 100 μM Na₃VO₄, 4 μg of leupeptin/ml) for 2 minutes .

• Gel selection: Use 4-20% Tris-glycine polyacrylamide gradient gels for optimal separation of SPAC607.02c.

• Protein transfer: Transfer to polyvinylidene difluoride (PVDF) membranes (Immobilon P) using standard electroblotting techniques .

• Antibody dilution: Begin with a 1:500 to 1:1000 dilution of the primary SPAC607.02c antibody and adjust based on signal strength. For secondary antibodies, a 1:25,000 dilution of HRP-conjugated anti-rabbit IgG typically provides good results .

• Detection method: Visualize using ECL detection systems and fluorescence scanning for optimal sensitivity .

• Loading control: Include anti-Cdc2p PSTAIR or anti-Arp3p as loading controls for S. pombe samples .

What are the critical considerations when designing immunoprecipitation experiments with SPAC607.02c antibody?

When designing immunoprecipitation (IP) experiments with SPAC607.02c antibody, consider these critical factors:

• Buffer composition: For native complexes, use NP-40 buffer without denaturation steps. For specific protein isolation, include a denaturation step with SDS buffer followed by dilution in NP-40 buffer .

• Antibody coupling: For efficient pull-down, couple the antibody to protein A-Sepharose using dimethyl pimelimidate (Sigma) before incubation with lysates. Typically, 20 μg of antibody coupled to 50 μl of protein A-Sepharose (1:1 slurry) provides good results .

• Incubation parameters: Perform immunoprecipitations for 1 hour on ice followed by a 30-minute incubation with the protein A-Sepharose slurry .

• Washing protocol: Wash immunoprecipitates six times with NP-40 buffer to minimize non-specific binding .

• Elution conditions: Elute bound proteins by resuspending the beads in sample buffer and heating.

• Controls: Include a non-specific IgG control and input samples to verify specificity and efficiency of the IP.

• Detection methods: For protein complex analysis, consider both Western blotting and mass spectrometry approaches. For radioactive detection, prepare 35S-labeled lysates by growing cells overnight in minimal medium followed by 4 hours growth with 1 mCi of 35S-Trans label prior to lysis .

How does the binding specificity of SPAC607.02c antibody compare to other S. pombe protein detection methods?

The binding specificity of SPAC607.02c antibody should be evaluated in context with other detection methods:

What are the recommended protocols for subcellular localization studies using SPAC607.02c antibody?

For subcellular localization studies using SPAC607.02c antibody, I recommend the following immunofluorescence protocol optimized for fission yeast:

• Cell fixation:

  • Fix cells in suspension with 3.7% formaldehyde for 30 minutes

  • Wash twice in 0.1 M potassium phosphate, pH 6.5 (K-Pi buffer)

  • Wash once in K-Pi buffer plus 1.2 M sorbitol (K-Pi/SORB)

  • Resuspend in 1 ml of K-Pi/SORB with 3 μl of β-mercaptoethanol and incubate for 10 minutes

• Cell wall digestion:

  • Add 30 μl of Zymolase 20T (10 mg/ml) and incubate for 30-60 minutes with rotation

  • Wash three times with K-Pi/SORB, once with K-Pi, once with K-Pi plus 0.1% NP-40, and once with K-Pi

• Antibody incubation:

  • Block with PBS containing 1% bovine serum albumin (PBAL) for 1 hour

  • Incubate with primary SPAC607.02c antibody (1:100-1:500 dilution) overnight at 4°C

  • Wash three times with PBAL

  • Incubate with fluorophore-conjugated secondary antibody (1:500-1:1000) for 1-2 hours

  • Wash three times with PBAL

• Imaging:

  • Mount cells with an anti-fade reagent containing DAPI for nuclear counterstaining

  • Image using confocal or fluorescence microscopy with appropriate filters

  • Capture z-stack images for complete cellular localization analysis

  • Process images using appropriate software (e.g., OpenLab, ImageJ)

• Co-localization studies:

  • For co-localization with known organelle markers, perform double immunofluorescence using differentially labeled secondary antibodies

  • Alternatively, combine with GFP-tagged organelle markers in appropriately constructed strains

How can I troubleshoot weak or non-specific signals when using SPAC607.02c antibody?

When encountering weak or non-specific signals with SPAC607.02c antibody, implement this systematic troubleshooting approach:

For weak signals:

• Antibody concentration: Increase primary antibody concentration incrementally (e.g., from 1:1000 to 1:500 or 1:250).

• Sample preparation: Ensure complete protein extraction by optimizing cell lysis conditions. For yeast cells, thorough disruption using glass beads is critical .

• Protein abundance: SPAC607.02c may be naturally low-abundance. Consider concentrating samples through immunoprecipitation before Western blotting .

• Detection system: Switch to more sensitive detection methods like ECL+ or fluorescence-based detection systems .

• Exposure time: Increase exposure time for Western blots or imaging acquisition time for immunofluorescence.

For non-specific signals:

• Blocking optimization: Increase blocking time or concentration (use 5% BSA or milk powder instead of 1%).

• Washing stringency: Increase washing steps (at least six washes) and duration with appropriate buffers .

• Antibody specificity: Test antibody specificity using peptide competition assays or knockout controls.

• Cross-reactivity reduction: Pre-absorb the antibody with yeast extract from a strain lacking SPAC607.02c to remove cross-reactive antibodies.

• Secondary antibody issues: Test secondary antibody alone to check for non-specific binding.

General optimization approaches:

What are the best approaches for quantifying SPAC607.02c protein levels in different experimental conditions?

For accurate quantification of SPAC607.02c protein levels across experimental conditions, consider these methodological approaches:

• Quantitative Western blotting:

  • Use denatured and clarified lysates normalized by bicinchoninic acid assay (BCA) to ensure equal protein loading

  • Include a dilution series of a reference sample to create a standard curve

  • Use fluorescently-labeled secondary antibodies rather than chemiluminescence for wider linear range

  • Quantify band intensities using densitometry software (e.g., ImageJ, Image Quant)

  • Normalize to an appropriate loading control (e.g., Cdc2p/PSTAIR, Arp3p)

• ELISA-based quantification:

  • Develop a sandwich ELISA using anti-SPAC607.02c as the capture antibody

  • Use a second antibody (different epitope or tagged protein approach) for detection

  • Generate a standard curve using recombinant SPAC607.02c protein

  • Validate the assay for linearity, recovery, and precision

• Flow cytometry approach:

  • For tagged versions of SPAC607.02c, use flow cytometry to quantify at single-cell level

  • Fix and permeabilize cells for intracellular staining with SPAC607.02c antibody

  • Include appropriate controls for autofluorescence and non-specific binding

• Mass spectrometry-based quantification:

  • Use SILAC (Stable Isotope Labeling with Amino acids in Cell culture) or TMT (Tandem Mass Tag) approaches

  • Employ selected reaction monitoring (SRM) for targeted quantification

  • Include appropriate internal standards for normalization

• Data analysis and reporting:

  • Always perform at least three biological replicates

  • Apply appropriate statistical tests based on experimental design

  • Report both absolute and relative changes in protein levels

  • Consider protein half-life and synthesis rate in interpreting changes

How can SPAC607.02c antibody be utilized in studying protein-protein interactions?

The SPAC607.02c antibody can be effectively employed to study protein-protein interactions through several methodological approaches:

• Co-immunoprecipitation (Co-IP):

  • Prepare native lysates without denaturation to preserve protein complexes

  • Perform immunoprecipitation with SPAC607.02c antibody following standard protocols

  • Analyze co-precipitated proteins by mass spectrometry or Western blotting

  • Include appropriate controls: IgG control, input samples, and where possible, SPAC607.02c knockout control

  • Consider crosslinking approaches to capture transient interactions

• Proximity-dependent labeling:

  • Generate fusion proteins between SPAC607.02c and BioID or APEX2

  • Identify proximal proteins through streptavidin pulldown and mass spectrometry

  • Validate interactions using the SPAC607.02c antibody in reciprocal Co-IP experiments

• Two-hybrid system validation:

  • Use yeast two-hybrid or mammalian two-hybrid systems to screen for interactions

  • Validate positive interactions through Co-IP with the SPAC607.02c antibody

  • Quantify interaction strength through various binding assays

• In situ proximity ligation assay (PLA):

  • Combine SPAC607.02c antibody with antibodies against suspected interacting partners

  • Visualize protein-protein interactions within intact cells

  • Quantify interaction signals using appropriate imaging software

• Sucrose gradient sedimentation:

  • Analyze complex formation through sucrose gradient sedimentation followed by fractionation

  • Detect SPAC607.02c and potential interacting partners in different fractions using specific antibodies

  • Compare migration patterns under different experimental conditions

What considerations are important when using SPAC607.02c antibody in chromatin immunoprecipitation (ChIP) experiments?

When adapting SPAC607.02c antibody for chromatin immunoprecipitation (ChIP) experiments, consider these critical methodological points:

• Antibody suitability assessment:

  • Verify that the antibody recognizes native (non-denatured) SPAC607.02c protein

  • Determine optimal antibody concentration for ChIP through titration experiments

  • Consider using epitope-tagged SPAC607.02c as a positive control system

• Crosslinking optimization:

  • Test different formaldehyde concentrations (typically 1-3%)

  • Optimize crosslinking time (typically 10-30 minutes)

  • For S. pombe, cell wall digestion with Zymolyase may be necessary for efficient crosslinking

• Chromatin fragmentation:

  • Optimize sonication conditions for S. pombe to achieve fragments of 200-500 bp

  • Verify fragmentation efficiency by agarose gel electrophoresis

  • Consider enzymatic fragmentation alternatives if sonication proves challenging

• Immunoprecipitation conditions:

  • Pre-clear chromatin with protein A/G beads to reduce background

  • Include appropriate negative controls (IgG, no antibody)

  • Consider using epitope tag antibodies (HA, Myc) as positive controls if tagged strains are available

• Washing stringency:

  • Implement stringent washing steps to reduce non-specific binding

  • Test different salt concentrations to optimize signal-to-noise ratio

  • Include detergents (e.g., 0.1% SDS, 1% Triton X-100) in wash buffers

• Data analysis considerations:

  • Normalize ChIP-qPCR data to input and IgG controls

  • For ChIP-seq, include spike-in controls for normalization across samples

  • Analyze enrichment patterns in context with known genomic features

How can SPAC607.02c antibody contribute to understanding protein degradation pathways in S. pombe?

The SPAC607.02c antibody can provide valuable insights into protein degradation pathways in S. pombe through these methodological approaches:

• Protein half-life determination:

  • Perform cycloheximide chase experiments to block new protein synthesis

  • Collect samples at different time points and analyze SPAC607.02c levels by Western blotting

  • Calculate protein half-life through quantitative analysis of degradation curves

  • Compare half-life under different environmental conditions or genetic backgrounds

• Ubiquitination analysis:

  • Immunoprecipitate SPAC607.02c under denaturing conditions

  • Probe with anti-ubiquitin antibodies to detect ubiquitination

  • Analyze ubiquitination patterns under different conditions (e.g., proteasome inhibition)

  • Identify specific ubiquitin linkage types using linkage-specific antibodies

• Proteasome-dependent degradation:

  • Treat cells with proteasome inhibitors (e.g., MG132, though cell wall permeability may require genetic modifications in S. pombe)

  • Compare SPAC607.02c levels with and without inhibitor treatment

  • Analyze interactions with proteasome components through Co-IP experiments

• Autophagy-mediated degradation:

  • Induce autophagy through nitrogen starvation or rapamycin treatment

  • Monitor SPAC607.02c levels under autophagy-inducing conditions

  • Use autophagy inhibitors to determine contribution to degradation

  • Analyze colocalization with autophagy markers using immunofluorescence

• Stress-induced degradation:

  • Subject cells to various stresses (heat shock, oxidative stress, etc.)

  • Monitor SPAC607.02c levels and modification state using the antibody

  • Correlate with stress response pathway activation

  • Identify stress-specific degradation mechanisms through genetic approaches

Can SPAC607.02c antibody be adapted for use in other fungal species or model organisms?

The potential for adapting SPAC607.02c antibody across species depends on sequence conservation and epitope mapping:

• Cross-reactivity assessment:

  • Perform sequence alignment analysis of SPAC607.02c across fungal species to identify conserved regions

  • The UPF0653 protein family is conserved among fungi, suggesting potential cross-reactivity

  • Test antibody reactivity with lysates from closely related yeasts (S. japonicus, S. octosporus)

  • Validate through Western blotting and immunoprecipitation in target species

• Epitope mapping considerations:

  • Determine the specific epitope(s) recognized by the antibody through peptide mapping

  • Synthesize peptides corresponding to the epitope region from other species

  • Perform competitive binding assays to assess epitope conservation

  • Consider developing new antibodies against highly conserved regions for cross-species applications

• Application-specific optimization:

  • Modify sample preparation protocols based on cell wall composition of target species

  • Adjust antibody concentrations and incubation conditions for each species

  • Validate specificity using genetic knockouts or knockdowns in target species

  • Develop species-specific positive and negative controls

• Alternative approaches:

  • For distant species, consider using antibodies against epitope-tagged homologs

  • Employ MS-based approaches for protein identification in species lacking validated antibodies

  • Develop recombinant antibody fragments with broader species reactivity

  • Use orthogonal detection methods to complement antibody-based approaches

What methodological approaches can combine SPAC607.02c antibody with cutting-edge technologies like CRISPR-Cas9 or single-cell analysis?

Integrating SPAC607.02c antibody with advanced technologies offers powerful new research capabilities:

• CRISPR-Cas9 gene editing applications:

  • Generate precise mutations or tagged versions of SPAC607.02c using CRISPR-Cas9

  • Use the antibody to validate editing outcomes at the protein level

  • Create cellular models with modified SPAC607.02c for functional studies

  • Implement CRISPR interference (CRISPRi) to modulate SPAC607.02c expression and monitor effects using the antibody

• Single-cell analysis integration:

  • Adapt intracellular staining protocols for single-cell protein analysis using SPAC607.02c antibody

  • Combine with single-cell RNA sequencing to correlate protein and transcript levels

  • Implement imaging mass cytometry for spatial distribution in heterogeneous populations

  • Develop microfluidic approaches for single-cell Western blotting using the antibody

• Proximity-dependent biotinylation:

  • Combine with TurboID or BioID fusion proteins to map the SPAC607.02c interactome

  • Validate proximity labeling results using conventional Co-IP with the antibody

  • Identify condition-specific or stimulus-dependent interactions

  • Map spatial protein networks through subcellular targeting of labeling enzymes

• Live-cell imaging approaches:

  • Use the antibody to validate and calibrate fluorescent protein fusions of SPAC607.02c

  • Develop antibody-based biosensors for detecting SPAC607.02c modifications

  • Implement antibody fragments for intracellular tracking applications

  • Correlate live imaging and fixed-cell antibody staining for comprehensive analysis

How can researchers combine experimental data from SPAC607.02c antibody studies with computational approaches for deeper biological insights?

Integrating experimental and computational methodologies provides comprehensive understanding of SPAC607.02c biology:

• Structural biology integration:

  • Use antibody-derived interaction data to validate or refine structural models

  • Map antibody epitopes onto predicted protein structures using computational approaches

  • Develop structure-based hypotheses for SPAC607.02c function that can be tested experimentally

  • Employ molecular dynamics simulations to understand conformational changes detected by the antibody

• Systems biology approaches:

  • Incorporate SPAC607.02c antibody-derived protein levels into multi-omics datasets

  • Build network models incorporating protein-protein interactions identified through IP-MS

  • Use machine learning to identify patterns in SPAC607.02c behavior across diverse conditions

  • Develop predictive models for SPAC607.02c regulation that can be experimentally validated

• Evolutionary analysis:

  • Compare experimental data on SPAC607.02c with homologs in other species

  • Analyze conservation patterns in the context of functional domains and interactions

  • Develop phylogenetic profiles based on both sequence and experimental data

  • Identify evolutionarily conserved vs. species-specific features for focused study

• Data integration pipelines:

  • Implement computational workflows that integrate antibody-based protein quantification with transcriptomics

  • Develop databases or repositories for SPAC607.02c-related data across experimental conditions

  • Apply statistical approaches appropriate for handling heterogeneous data types

  • Utilize visualization tools to represent complex datasets in interpretable formats

These integrated approaches connect molecular-level observations to broader biological contexts, enabling researchers to develop comprehensive models of SPAC607.02c function within cellular systems.